Skip to main content

CinCor Pharma, Inc.

CINCDelisted Feb 24, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001868734

CinCor Pharma, Inc. was delisted on Feb 24, 2023; its insiders filed their last Form 4 on Feb 28, 2023; 102 institutions reported holding it in 13F filings for Q4 2022, worth $460.7M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding CinCor Pharma, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CINC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders53157+5
Shares29.6M2.27K31.6M+1.99M (+6.7%)
Value$519.8M$40.0K$595.6M+$75.8M (+14.6%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held CinCor Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CINC in Q2 2022
InstitutionSharesValue% of portfolio
Driehaus Capital Management LLC487,279$9.18M0.15%
Artal Group S.A.137,010$2.58M0.14%
Integral Health Asset Management, LLC41,748$787.0K0.16%
Swiss National Bank31,100$586.0K0.00%
Rhumbline Advisers19,105$360.0K0.00%
Credit Suisse AG10,193$192.0K0.00%
Advisor Group Holdings, Inc.4,676$95.0K0.00%
Captrust Financial Advisors109$2.00K0.00%
Glassman Wealth Services45$1.00K0.00%

Sold out (4)

Institutions that held CinCor Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CINC in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Caas Capital Management LP75,000$1.32M
Point72 Hong Kong Ltd22,064$387.0K
Davidson Kempner Capital Management LP15,000$262.0K
Millennium Management LLC12,000$210.0K

Not filed for Q2 2022 yet (1)

Institutions that held CinCor Pharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CINC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.2,271$40.0K